Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Quest Diagnostics Investments LLC, a subsidiary of Quest Diagnostics, Inc., is an American company specializing in medical laboratories.

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Guangzhou Darui Biotechnology Co., Ltd. engages in the research and development, and application of prenatal and postnatal care, and precision medical products. Its products and instruments are used in prenatal screening, screening of newborns, cancer screening and individualized drug guide, detection of infectious diseases, and sex hormone test. Its technology platform includes high-throughput sequencing, gene chip, flight mass spectrometry, chemiluminescent, time-resolved, and tandem mass spectrometry platform. The company was founded on August 11, 2003 and is headquartered in Guangzhou, China.

Genes Laboratories, Inc. researches and develops on biotechnology. Its products include PCR, Direct PCR, Real-time PCR, DNA/RNA Prep, Buffer & Reagents, Diagnostics and Instrument. The company was founded in November 2008 and is headquartered in Seongnam, Korea.

Jiangsu Bailing Whole Gene Biomedical Technology Co., Ltd., established on 2009-09-16, Business scope includes biological products,biotechnology development,transfer,technical consulting,Technical Services(Excluding production and sales);Medical Technology Consulting;Laboratory Instrument Sales(except medical devices).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

CoWin Biosciences (CWBIO) provides high-quality biology reagents in life science research and molecular diagnostics field. They have developed more than 1000 products for Nucleic Acid Extraction & Purfication, PCR, Real-time PCR, Markers, Library Preparation for Next Generation Sequencing, Sample Perservative, Molecular Diagnostics and Protein Assays. CWBIO was founded in 2007 with the total investment of more than of 10 million US dollars. With advanced instruments and facilities, workshops which were fully in line with national GMP standards and international manufacture technology applied to all the products. In 2014, they have been certified to ISO9001:2008 and ISO13485:2003 quality standards. Their products are used by thousands of scientists around the world and cited in more than 1,000 peer-reviewed publications.

Shanghai Bodao Gene Technology Co., Ltd., established on 1998-12-17, Business scope includes bioengineering,Technology transfer in the field of genetic engineering,to develop,consult,Production, supply and marketing of services and related reagents and equipment. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shenzhen Huizhong Biotechnology Co., Ltd., established on 2017-10-26, Business scope includes general business items:Biotechnology Consulting,technology development,technology transfer,Technical Services;medical technology development;Technical development of in vitro diagnostic reagents,Technical service and sales;Technical development of inspection and analysis instruments;Import and export of goods and technology.,The licensing program is:Sales of Medical Devices.

HEAS BioTech provides biological sample processing, molecular pathology, and POCT services. HEAS BioTech has built an R&D center of 1,400 square meters, a GMP standard production plant of 2,200 square meters, and a production system for medical reagents and equipment.

Beijing Xinnuo Best Medical Laboratory Co., Ltd., established on 2014-08-28, The scope of business includes medical laboratory;Clinical Cytomolecular Genetics Major/Pathology(The medical institution practice license is valid until2020year08moon04day);Health Advisory(Except for medical treatment activities subject to approval);Technology development of biological gene detection,technology transfer,Technology Promotion,technical consulting,Technical Services;retail chemical products(Free of Hazardous Chemicals),Instrumentation,Equipment,electronic product,Computer software and auxiliary equipment,daily necessities.(Enterprises independently choose operating projects according to law,Carry out business activities;Medical Laboratory;Clinical Cytomolecular Genetics Major/Department of Pathology and programs subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)

Hangzhou Fangxia Biotechnology Co., Ltd., established on 2018-03-30, Business scope includes services:medical technology,Biotechnology,Medical Diagnostic Technology,Technology Development of Medical Testing Technology,technical consulting,Technical Services,technology transfer,Computer hardware and software,biological instrument,medical instrument,Diagnostic reagents,laboratory instrument,Research and development of laboratory reagents and consumables,Data analysis service,Biotechnology-related technical consulting services,Non-medical health information consultation(Except those who need a medical qualification certificate);wholesale,retail:Computer hardware and software,biological instrument,medical instrument,Diagnostic reagents,laboratory instrument,Laboratory reagents and consumables,Class I medical device;Import and export business of goods and technology(National law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations can only be operated after obtaining a license)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Likang Pharmaceutical Technology Co. Ltd. is a Chinese private company located in Shanghai. The firm produces and distributes pharmaceutical drugs.

Xiamen Baiouxun Biotechnology Co., Ltd., established on 2019-01-10, Business scope includes general items:Technology promotion and application services;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:pharmaceutical production;Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices;Technology Import and Export;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Beijing Huarui Kangyuan Biotechnology Development Co., Ltd., established on 2017-10-19, The business scope includes the sale of third-class medical devices;production first class,second category,Class III medical devices;biological reagent,medical instruments,software technology development,technical consulting,Technical Services,technology transfer;software development;Computer System Services;SalesIkind,IIclass of medical devices,computer software,Hardware and Auxiliary Equipment,Equipment,Instrumentation,Chemical Products(Free of Hazardous Chemicals),Wujinjiaodian;Mechanical and electrical equipment rental;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Import and export,Agent import and export,Technology Import and Export;Technical testing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Beijing Microread Genetics Co., Ltd. is a company headquartered in Beijing, China. The firm develops test reagents for clinical, forensic, agricultural, animal husbandry and research fields. It was founded in 2009.